Acta Scientific Orthopaedics (ISSN: 2581-8635)

Case Report Volume 4 Issue 10

Vaccine Administration Leading to Subacromial Bursitis

Ravin Patel*, Irfan Chhipa, Mitesh Patel and Sunny Gupta

Department of Family Medicine, Inspira Health Network, United States

*Corresponding Author: Ravin Patel, Department of Family Medicine, Inspira Health Network, United States.

Received: August 11, 2021; Published: September 09, 2021

Abstract

  Shoulder injury related to vaccine administration (SIRVA) describes the condition of injury to the shoulder joint after incorrect or inaccurate placement of intramuscular injections intended for the deltoid muscle. Vaccine placement inherently carry multiple risks given the vasculature, neural intervention and anatomy of the shoulder joint.

  We present a patient that presented with a chief complaint of left shoulder pain occurring for two months. This patient failed conservative management with non-steroidal anti-inflammatory drugs and oral steroids which were recommended by his primary care physician. He was ultimately referred to orthopedics given his lack of improvement and persistence of pain with an active range of motion and overhead movements. After significant work including history taking, physical examination and imaging this patient was diagnosed with SIRVA. This patient was treated successfully with subacromial cortisone injection with complete resolution of his symptomatology.

  Our aim with this case is to urge clinicians to maintain a high index of suspicion for SIRVA in individuals presenting for acute shoulder pain. It is important to consider recent administration of vaccines through a thorough history and physical exam in order to accurately diagnose SIRVA in patients. This is especially true with the increased prevalence of vaccinations against COVID-19 which we will see in the upcoming months.

Keywords: Vaccine; Subacromial Bursitis; Shoulder Injury Related to Vaccine Administration (SIRVA)

References

  1. Atanasoff S., et al. “Shoulder injury related to vaccine administration (SIRVA)”. Vaccine51 (2010): 8049-8052.
  2. Bodor M and Montalvo E. “Vaccination-related shoulder dysfunction”. Vaccine4 (2007): 585-587.
  3. Cantarelli Rodrigues T., et al. “Subacromial-subdeltoid bursitis following COVID-19 vaccination: a case of shoulder injury related to vaccine administration (SIRVA)”. Skeletal Radiology (2021): 1-5.
  4. Cross G. “Don’t aim too high: Avoiding shoulder injury related to vaccine administration”. Australian Family Physician 5 (2016): 303-306.
  5. Hesse EM., et al. “Risk for Subdeltoid Bursitis After Influenza Vaccination”. Annals of Internal Medicine 4 (2020): 253-261.
  6. Hibbs BF., et al. “Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine”. Vaccine Adverse Event Reporting System (VAERS) (2020).
  7. Holder J. “Tracking coronavirus VACCINATIONS around the world”. The New York Times (2021).
  8. Holmes RE., et al. “Clinical evaluation of nonarthritic shoulder pain: Diagnosis and treatment”. The Physician and Sports Medicine3 (2015): 262-268.
  9. Macomb CV., et al. “Treating SIRVA Early With Corticosteroid Injections: A Case Series”. Military Medicine1-2 (2020): e298-e300.
  10. Martín Arias LH., et al. “Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations”. Vaccine37 (2017): 4870-4876.
  11. Vaccine injury compensation data. Official web site of the U.S. Health Resources and Services Administration (2021).

Citation

Citation: Ravin Patel., et al. “Vaccine Administration Leading to Subacromial Bursitis".Acta Scientific Orthopaedics 4.10 (2021): 28-32.

Copyright

Copyright: © 2021 Ravin Patel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US